A review on various heterocyclic moieties and their antitubercular activity
Authors:
- 1 July 2011
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 65 (4) , 244-251
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- New 3-methylquinoxaline-2-carboxamide 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agentsBioorganic & Medicinal Chemistry, 2010
- Synthesis and evaluation of in vitro anti-microbial and anti-tubercular activity of 2-styryl benzimidazolesEuropean Journal of Medicinal Chemistry, 2009
- Synthesis, structural activity relationship and anti-tubercular activity of novel pyrazoline derivativesEuropean Journal of Medicinal Chemistry, 2007
- Novel fluoroquinolones: design, synthesis, and in vivo activity in mice against Mycobacterium tuberculosis H37RvBioorganic & Medicinal Chemistry Letters, 2005
- Quantitative relationships for specific growth rates and macromolecular compositions of Mycobacterium tuberculosis, Streptomyces coelicolor A3(2) and Escherichia coli B/r: an integrative theoretical approachMicrobiology, 2004
- Application of stains in clinical microbiologyBiotechnic & Histochemistry, 2001
- Mycobacterium canettii , the Smooth Variant of M. tuberculosis , Isolated from a Swiss Patient Exposed in AfricaEmerging Infectious Diseases, 1998
- A Novel Pathogenic Taxon of the Mycobacterium tuberculosis Complex, Canetti: Characterization of an Exceptional Isolate from AfricaInternational Journal of Systematic and Evolutionary Microbiology, 1997
- Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonistsJournal of Medicinal Chemistry, 1988
- Plasma Hydrazine Concentrations in Man after Isoniazid and Hydralazine AdministrationHuman Toxicology, 1985